Sotera Health Appoints Karen Flynn to Board of Directors
November 13 2023 - 7:00AM
Sotera Health Company (Nasdaq: SHC), a leading global provider
of mission-critical end-to-end sterilization solutions and lab
testing and advisory services for the healthcare
industry, announced today it has appointed Karen Flynn as a
new independent director to its Board.
Ms. Flynn is an accomplished healthcare leader with over 35
years of commercial, operations and general management experience
in the pharmaceutical services industry. She most recently served
as Interim President of BioModalities at Catalent (NYSE: CTLT), a
global provider of development and manufacturing solutions for
drugs, biologics, cell and gene therapies and consumer health
products. Prior to this, she held the positions of Chief Commercial
Officer and President of Biologics at Catalent. Prior to Catalent,
she served as Senior Vice President and Chief Commercial Officer
for West Pharmaceutical Services (NYSE: WST), and as President of
its Pharmaceutical Packaging Systems business. In addition to her
experience leading high-growth businesses, Ms. Flynn brings an
extensive background in commercial strategy, strategic planning and
innovation and quality management.
“We are excited to welcome Karen to our Board of Directors,”
said Michael B. Petras, Jr., Chairman and Chief Executive Officer
of Sotera Health. “Karen’s extensive commercial expertise in
pharmaceutical services will serve as a tremendous asset as we
continue to grow. Additionally, her strong Board leadership and
governance experience will be valuable as we advance as a public
company.”
Ms. Flynn currently serves on the Board of Directors of
Quanterix Corporation (Nasdaq: QTRX), where she is a member of the
Compensation and Nominating and Governance Committees and on the
Board of Directors of Catalent. She has also served on the Board of
Recro Pharma, Inc., a specialty pharma and contract development and
manufacturing organization, where she was Chair of the Compensation
Committee and a member of the Audit Committee.
Ms. Flynn holds a Master of Science in Engineering from
University of Pennsylvania and a Master of Science in Business
Administration from Boston University. She completed her Bachelor
of Science at the University of Notre Dame.
About Sotera HealthSotera Health Company is a
leading global provider of mission-critical end-to-end
sterilization solutions and lab testing and advisory services for
the healthcare industry. Sotera Health goes to market through three
businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health
is committed to its mission, Safeguarding Global Health®.
Contacts
Jason PetersonVice President & Treasurer, Sotera
HealthIR@soterahealth.com
Kristin GibbsChief Marketing Officer, Sotera
Healthkgibbs@soterahealth.com
Source: Sotera Health Company
Sotera Health (NASDAQ:SHC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sotera Health (NASDAQ:SHC)
Historical Stock Chart
From Aug 2023 to Aug 2024